
Pharmacally
Bivamelagon
Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.
Latest in Bivamelagon
Clinical TrialsRhythm Highlights Long-Term Setmelanotide and Bivamelagon Data Across Rare MC4R Pathway Disorders at ENDO 2026New data presented at ENDO 2026 showed sustained BMI reductions with setmelanotide in acquired hypothalamic obesity, continued weight-loss benefits with oral MC4R agonist bivamelagon, and real-world improvements in…Fact-Checked
Explore more
Health TidingsIndustry, pipeline and company news.
RegulatoryApprovals, policy and agency decisions.
ResearchPeer-reviewed studies and scientific breakthroughs.
Drug FinderLook up any drug: uses, dosing and safety.
From the HistoryLandmark moments in pharmaceutical history.
LatestEvery new story, as soon as it is published.